26
Participants
Start Date
March 31, 2010
Primary Completion Date
March 31, 2013
Study Completion Date
March 31, 2013
Docetaxel
Docetaxel: 60mg/m2 i.v on day 1. Cycle repeated ever 3 weeks
Bevacizumab
Bevacizumab: 7.5 mg/kg, iv on day 1. Cycle repeated every 3 weeks
University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece, Heraklion
"Laikon General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine", Athens
401 Military Hospital of Athens, Athens
Air Forces Military Hospital of Athens Athens, Greece, Athens
Medical Oncology Unit NIMTS (Veterans Hospital), Athens
Lead Sponsor
Hellenic Oncology Research Group
OTHER